K. Nackaerts

J. Crowley, G. Giaccone, A. Nicholson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, American journal of respiratory and critical care medicine.

Management of lung nodules detected by volume CT scanning.

Harry J de Koning, Mathias Prokop, Matthijs Oudkerk, 2009, The New England journal of medicine.

Operational monitoring of green biomass change for forest management

Pol Coppin, K. Nackaerts, P. Coppin, 2001 .

Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heparan sulfate proteoglycan expression in human lung‐cancer cells

K. Nackaerts, G. Deneffe, E. Verbeken, 1997, International journal of cancer.

Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.

K. Nackaerts, M. Socinski, F. Shepherd, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Harry J de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, 2014, The Lancet. Oncology.

18 fluoro-2-deoxyglucose positron emission tomography (PET) in the assessment of induction chemotherapy in stage IIIA-N2 NSCLC: a multi-center prospective study

K. Nackaerts, L. Mortelmans, A. Lammertsma, 2001 .

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

K. Nackaerts, O. Riesterer, R. Stahel, 2015, The Lancet. Oncology.

Tremelimumab as second- or third-line treatment of unresectable malignant mesothelioma (MM): Results from the global, double-blind, placebo-controlled DETERMINE study.

K. Nackaerts, J. Aerts, F. Grosso, 2016 .

Severe intestinal ischemia during chemotherapy for small cell lung cancer.

K. Nackaerts, B. Legius, 2017, Lung cancer management.

ESR/ERS white paper on lung cancer screening

H. Kauczor, K. Nackaerts, M. Prokop, 2015, European Respiratory Journal.

Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study

K. Nackaerts, D. de Ruysscher, S. Peeters, 2016, Acta oncologica.

Serial Measurements of Mesothelioma Serum Biomarkers in Asbestos-Exposed Individuals: A Prospective Longitudinal Cohort Study

S. Vansteelandt, K. Nackaerts, J. V. van Meerbeeck, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.

K. Nackaerts, L. Kasten, S. Novello, 2022, The Lancet. Oncology.

Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).

K. Nackaerts, M. Socinski, F. Shepherd, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.

K. Nackaerts, O. Riesterer, R. Stahel, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Plant species richness and composition of heathland relics in north‐western Belgium: evidence for a rescue‐effect?

K. Nackaerts, O. Honnay, M. Hermy, 2004 .

On the impact of residential history in the spatial analysis of diseases with a long latency period: A study of mesothelioma in Belgium

C. Faes, K. Nackaerts, T. Neyens, 2020, Statistics in medicine.

Strengths, Weaknesses, and Opportunities of Diagnostic Breathomics in Pleural Mesothelioma—A Hypothesis

K. Nackaerts, J. V. van Meerbeeck, K. Lamote, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Lymph node mapping in non-small cell lung cancer with FDG-PET scan: a prospective study in 690 LN levels from 68 patients

K. Nackaerts, J. Bogaert, P. Dupont, 1997 .

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

C. Dooms, K. Nackaerts, D. de Ruysscher, 2016, Radiotherapy and Oncology.

Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lu

K. Nackaerts, L. Mortelmans, J. Vansteenkiste, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective Comparative Study of Integrated Positron Emission Tomography-Computed Tomography Scan Compared With Remediastinoscopy in the Assessment of Residual Mediastinal Lymph Node Disease After Induction Chemotherapy for Mediastinoscopy-Proven Stage IIIA-N 2 Non – Small-Cell Lung Cancer : A Leuve

K. Nackaerts, L. Mortelmans, J. Vansteenkiste, 2006 .

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Fergus Gleeson, Heber MacMahon, Jin Mo Goo, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Changes in pulmonary function up to 10 years after locoregional breast irradiation.

M. Decramer, K. Nackaerts, Y. Lievens, 2012, International journal of radiation oncology, biology, physics.

Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease.

M. Decramer, K. Nackaerts, D. Lambrechts, 2010, American journal of respiratory and critical care medicine.

Low-dose CT screening for lung cancer: trial and error?

K. Nackaerts, J. Vansteenkiste, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

OA 02.01 Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Metastatic Pleural Mesothelioma

K. Nackaerts, S. Novello, G. Ceresoli, 2017 .

Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature

C. Dooms, K. Nackaerts, B. Weynand, 2022, EJNMMI Research.

Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients

K. Nackaerts, F. Mottaghy, K. Haustermans, 2016, Nuklearmedizin.

Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

K. Nackaerts, J. Vansteenkiste, M. Demedts, 1997, The Annals of thoracic surgery.

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies

K. Nackaerts, E. Van Cutsem, K. Goffin, 2021, Cancers.

An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer.

K. Nackaerts, J. Vansteenkiste, E. Verbeken, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Soluble Mesothelin, Megakaryocyte Potentiating Factor, and Osteopontin as Markers of Patient Response and Outcome in Mesothelioma

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

THE ROLE OF A CONVENTIONAL BRONCHOSCOPY IN THE WORK-UP OF SUSPICIOUS CT SCREEN DETECTED PULMONARY NODULES

R. Vernhout, K. Nackaerts, C. Weenink, 2011 .

Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation

K. Nackaerts, L. Annemans, P. Bartsch, 2015, Preventive medicine reports.

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.

K. Nackaerts, C. Weenink, J. Lammers, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

C. Dooms, K. Nackaerts, D. Lambrechts, 2018, Radiation Oncology.

Gefitinib monotherapy in advanced non-small cell lung cancer (NSCLC): Experience from a large, Western community implementation study

K. Nackaerts, J. Canon, J. Vansteenkiste, 2006 .

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

K. Nackaerts, Siân Jones, A. Chiang, 2020 .

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for Small-Cell Lung Cancer: Primary and Correlative Biomarker Analyses.

K. Nackaerts, Siân Jones, A. Chiang, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Baseline and second round results from the population based Dutch-Belgian randomized lung cancer screening trial (NELSON)

K. Nackaerts, M. Oudkerk, W. Mali, 2008 .

Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer

K. Nackaerts, H. Wildiers, J. Vansteenkiste, 2017, Lung.

A practical guide to measure "all" malignant pleural mesothelioma tumors by modified RECIST criteria?

K. Nackaerts, J. Vansteenkiste, P. Nafteux, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

K. Nackaerts, H. Groen, N. Reinmuth, 2021 .

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors.

K. Nackaerts, F. Mottaghy, F. De Keyzer, 2022, Radiology. Imaging cancer.

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

H. D. de Koning, K. Nackaerts, C. Weenink, 2013, European Respiratory Journal.

Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT

K. Nackaerts, K. Van Laere, E. Van Cutsem, 2020, Acta oncologica.

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation

K. Nackaerts, L. Annemans, P. Bartsch, 2009, Clinical drug investigation.

Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

K. Nackaerts, F. Mottaghy, L. Mortelmans, 2016, European Radiology.

Real-life treatment practice for malignant pleural mesothelioma in Belgium.

K. Nackaerts, J. V. van Meerbeeck, H. De Schutter, 2018, Lung cancer.

Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?

K. Nackaerts, D. de Ruysscher, D. Ruysscher, 2017, Strahlentherapie und Onkologie.

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma.

K. Nackaerts, J. von Pawel, U. Gatzemeier, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma

K. Nackaerts, J. V. van Meerbeeck, Eline Schillebeeckx, 2022, Cancers.

Randomized phase 2 study of investigational aurora A kinase (AAK) inhibitor alisertib (MLN8237) + paclitaxel (P) vs placebo + P as second line therapy for small-cell lung cancer (SCLC)

K. Nackaerts, T. Owonikoko, D. Spigel, 2016 .

Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report

K. Nackaerts, E. Wauters, Jonas Claus, 2019, Lung cancer management.

C. Dooms, K. Nackaerts, K. Laere, 2022, EJNMMI Research.

An unusual presentation of a more common disease entity

K. Nackaerts, C. Deroose, E. Verbeken, 2018, Breathe.

Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.

K. Nackaerts, J. Vansteenkiste, M. Demedts, 2001, Lung cancer.

Electronic Nicotine Delivery Systems

K. Nackaerts, L. Joossens, Michael Burke, 2016, Pediatric Clinical Practice Guidelines & Policies.

Asbestos bodies in bronchoalveolar lavage in the 21st century: a time-trend analysis in a clinical population

K. Nackaerts, Valerie Nuyts, B. Nemery, 2016, Occupational and Environmental Medicine.

Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study

K. Nackaerts, P. Sterk, J. V. van Meerbeeck, 2017, Oncotarget.

Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)

K. Nackaerts, J. V. van Meerbeeck, O. Thas, 2016, Journal of breath research.

Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab

K. Nackaerts, P. Neven, H. Wildiers, 2018, Acta clinica Belgica.

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

K. Nackaerts, P. Neven, H. Wildiers, 2018, Supportive Care in Cancer.

Inflammation-Based Index and 68Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC

K. Nackaerts, F. Mottaghy, K. Haustermans, 2019, The Journal of Nuclear Medicine.

The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992).

G. Giaccone, M. J. van de Vijver, K. Nackaerts, 2003, European journal of cancer.

Lung Cancer in Belgium.

K. Nackaerts, B. Weynand, J. V. van Meerbeeck, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

K. Nackaerts, U. Dafni, K. Syrigos, 2022, Modern Pathology.

Ramsay Hunt syndrome: a rare complication of herpes zoster infection in a lung cancer patient

K. Nackaerts, T. Mercier, G. Deslypere, 2018, Acta clinica Belgica.

Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall.

K. Nackaerts, J. Duerr, A. Danneels, 1995, Atherosclerosis.

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

K. Nackaerts, J. Aerts, F. Grosso, 2017, The Lancet. Oncology.

A fatal case of cholestatic liver failure probably related to gemcitabine.

K. Nackaerts, J. Vansteenkiste, M. Demedts, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Robust disease control following sequential immunotherapy and radiotherapy in a malignant pleural mesothelioma patient

K. Nackaerts, K. Vanhove, M. Lambrecht, 2020 .

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.

K. Nackaerts, P. Dupont, L. Mortelmans, 1997, Chest.

Commentary: Do we need to search for a patient's cigarettes or just count his or her wrinkles when counseling for lung cancer resection?

K. Nackaerts, P. D. De Leyn, H. Decaluwé, 2020, The Journal of thoracic and cardiovascular surgery.

Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: a case report

C. Dooms, K. Nackaerts, E. Wauters, 2022, Current Problems in Cancer: Case Reports.

Smoking cessation: a clinical update

G. Verleden, M. Decramer, K. Nackaerts, 2008, European Respiratory Review.

Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome.

K. Nackaerts, S. Fieuws, S. Heye, 2013, AJR. American journal of roentgenology.

Man and environment in the territory of Sagalassos, a classical city in SW Turkey

K. Nackaerts, A. Steegen, Gerard Govers, 1999 .

ESR/ERS white paper on lung cancer screening

H. Kauczor, K. Nackaerts, M. Prokop, 2015, European Respiratory Journal.

Disease mapping method comparing the spatial distribution of a disease with a control disease

C. Faes, K. Nackaerts, T. Neyens, 2022, Biometrical journal. Biometrische Zeitschrift.

COCCIDIOIDOMYCOSIS: AN UNEXPECTED DIAGNOSIS IN A PATIENT WITH PERSISTENT COUGH

K. Nackaerts, E. Verbeken, K. Lagrou, 2009, Acta clinica Belgica.

Persistent Cough in a Young Smoker

K. Nackaerts, E. Verbeken, K. Lagrou, 2009, Respiration.

Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.

Rozemarijn Vliegenthart, Matthijs Oudkerk, Harry J M Groen, 2017, Lung cancer.

Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium.

K. Nackaerts, J. V. van Meerbeeck, H. De Schutter, 2018, Lung cancer.

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients

K. Nackaerts, G. Pravettoni, D. Monzani, 2021, Frontiers in Public Health.

Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.

K. Nackaerts, Y. Humblet, J. Vansteenkiste, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Thorax.

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2010, American journal of respiratory and critical care medicine.

PATHOLOGIC COMPLETE REMISSION OF MALIGNANT PLEURAL MESOTHELIOMA AFTER COMBINED MODALITY TREATMENT: A CASE REPORT

K. Nackaerts, Y. Lievens, E. Verbeken, 2013, Acta clinica Belgica.

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.

H. Thierens, K. Nackaerts, J. V. van Meerbeeck, 2010, Pharmacogenomics.

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis.

K. Nackaerts, J. Reitsma, H. Pass, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

20 – Clinical Presentation and Prognostic Factors in Lung Cancer

K. Nackaerts, Keunchil Park, K. Fong, 2018 .

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

C. Dooms, K. Nackaerts, A. Warth, 2019, Modern Pathology.

Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis

C. Dooms, K. Nackaerts, D. Lambrechts, 2022, Journal for ImmunoTherapy of Cancer.

Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer.

K. Nackaerts, D. de Ruysscher, D. Ruysscher, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

K. Nackaerts, R. Stahel, A. Santoro, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.

C. Dooms, K. Nackaerts, S. Dymarkowski, 2012, Radiology.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, N. Girard, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging.

C. Dooms, K. Nackaerts, S. Dymarkowski, 2015, Radiology.

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Harry J de Koning, Mathias Prokop, Rozemarijn Vliegenthart, 2020, The New England journal of medicine.

The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial

H. D. de Koning, R. Vernhout, K. Nackaerts, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Suitability of Small Bronchoscopic Tumour Specimens for Lung Cancer Genotyping

C. Dooms, K. Nackaerts, V. Ninane, 2014, Respiration.

Accurate determination of copy number variations (CNVs): application to the alpha- and beta-defensin CNVs.

K. Nackaerts, J. Vermeesch, S. Vermeire, 2009, Journal of immunological methods.

Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2003, Lung cancer.

Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.

K. Nackaerts, J. Vansteenkiste, M. Demedts, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer

C. Dooms, K. Nackaerts, B. Weynand, 2018, Respiration.

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study

C. Dooms, K. Nackaerts, T. Roskams, 2014, Translational Respiratory Medicine.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

C. Dooms, K. Nackaerts, D. Lambrechts, 2018, Radiation oncology.

Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 TAHOE Study.

K. Nackaerts, H. Groen, N. Reinmuth, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Randomized, Placebo‐Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum‐Based Chemotherapy as First‐Line Treatment for Extensive‐Stage Small‐Cell Lung Cancer

K. Nackaerts, R. Ramlau, L. Paz-Ares, 2017, Clinical lung cancer.

Modeling genetic connectivity in sticklebacks as a guideline for river restoration

K. Nackaerts, J. Raeymaekers, G. Maes, 2008, Evolutionary applications.

Screening and early detection of lung cancer.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2012, Chest.

Quantifying asbestos in lung tissue: what debate?

K. Nackaerts, Valerie Nuyts, B. Nemery, 2017, European Respiratory Journal.

C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)

K. Nackaerts, R. Stahel, A. Santoro, 2007 .

Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy - Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.

K. Nackaerts, U. Dafni, D. de Ruysscher, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of NGS and RT‐PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

C. Dooms, K. Nackaerts, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review

K. Nackaerts, W. van Paesschen, P. Demaerel, 2017, Acta clinica Belgica.

Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.

K. Nackaerts, P. Dendale, T. de Smedt, 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting

K. Nackaerts, F. Petrella, G. Pravettoni, 2021, Frontiers in Medicine.

LATE RECURRENT OVARIAN CARCINOMA METASTATIC TO THE THORACIC WALL

K. Nackaerts, F. Amant, D. Testelmans, 2010, Acta clinica Belgica.

Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases

K. Nackaerts, J. Vansteenkiste, M. Demedts, 1997 .

Low-dose computed tomography screening for lung cancer: results of the first screening round.

H. D. de Koning, K. Nackaerts, M. Oudkerk, 2013, Journal of Comparative Effectiveness Research.

Review ArticleDigital change detection methods in ecosystem monitoring: a review

Pol Coppin, Eric F. Lambin, Bart Muys, 2004 .

PREDICTORS OF QUIT SUCCESS IN BELGIAN PARTICIPANTS OF A VARENICLINE OBSERVATIONAL SMOKING CESSATION STUDY

K. Nackaerts, H. Boudrez, M. Messig, 2013, Acta clinica Belgica.

Exhaled breath to screen for malignant pleural mesothelioma: a validation study

K. Nackaerts, J. V. van Meerbeeck, O. Thas, 2017, European Respiratory Journal.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography–computed tomography?

C. Dooms, K. Nackaerts, D. de Ruysscher, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

ESR/ERS white paper on lung cancer screening

H. Kauczor, K. Nackaerts, M. Prokop, 2015, European Radiology.

The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.

H. D. de Koning, R. Vernhout, K. Nackaerts, 2012, Chest.

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer - A prospective analysis of 50 cases

K. Nackaerts, P. Dupont, L. Mortelmans, 1997 .

Lung cancer mortality and fine particulate air pollution in Europe

K. Nackaerts, T. Nawrot, B. Nemery, 2007, International journal of cancer.

Bisphosphonates: Prevention of Bone Metastases in Lung Cancer

K. Nackaerts, K. Syrigos, V. Hirsh, 2012 .

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial

K. Nackaerts, P. Hajek, T. McRae, 2014, Clinical pharmacology and therapeutics.

Skin lesions in a lung cancer patient

K. Nackaerts, E. Verbeken, A. Vrancken, 2015, Acta clinica Belgica.

Smoking cessation rates after a nurse-led inpatient smoking cessation intervention

K. Nackaerts, P. Vermeire, H. Boudrez, 2010 .

Blinded and uniform cause of death verification in a lung cancer CT screening trial.

H. D. de Koning, K. Nackaerts, C. Weenink, 2012, Lung cancer.

Implicit attitudes towards smoking predict long-term relapse in abstinent smokers

K. Nackaerts, J. de Houwer, Adriaan Spruyt, 2015, Psychopharmacology.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2016, Thorax.

Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study

K. Nackaerts, J. Canon, J. Vansteenkiste, 2006, European Respiratory Journal.

Influenza season influence on outcome of new nodules in the NELSON study

K. Nackaerts, M. Heuvelmans, F. M. Mohamed Hoesein, 2023, Scientific reports.

Maintenance Therapy for Advanced Non–Small-Cell Lung Cancer: A Pilot Study on Patients’ Perceptions

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.

R. Vernhout, K. Nackaerts, R. V. van Klaveren, 2010, Lung cancer.

Assessment of automatic gap fraction estimation of forests from digital hemispherical photography

Pol Coppin, Kris Nackaerts, Bart Muys, 2005 .

LBA84 Consolidation ipilimumab and nivolumab vs observation in limited stage SCLC after chemo-radiotherapy: Results from the ETOP/IFCT 4-12 STIMULI trial

K. Nackaerts, U. Dafni, D. Ruysscher, 2020 .

Clinical factors predictive of long-term survival in advanced non-small cell lung cancer.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2013, Lung cancer.

Methods for Leaf Area Index Determination Part I : Theories , Techniques and Instruments

Frédéric Baret, Pol Coppin, Stefan Fleck, 2003 .

Patterns of population genetic diversity in riparian and aquatic plant species along rivers

K. Nackaerts, H. Jacquemyn, O. Honnay, 2010 .

Evaluation of a lightweigth UAS-prototype for hyperspectral imaging

J. Everaerts, H. Saari, B. Delauré, 2010 .

LBA78 A microsimulation model to assess the impact of SARS-CoV-2 on cancer outcomes, healthcare organization and economic burden

C. Dooms, K. Nackaerts, D. Lambrechts, 2020, Annals of Oncology.

Randomized phase 3 trial of amrubicin versus topotecan as second-line treatment for small cell lung cancer (SCLC)

K. Nackaerts, M. Socinski, F. Shepherd, 2012 .

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

K. Nackaerts, R. Stahel, W. Weder, 2015, Lung cancer.

Bisphosphonates: prevention of bone metastases in lung cancer.

K. Nackaerts, F. de Marinis, K. Syrigos, 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Hierarchical image segmentation based on similarity of NDVI time series

Jan Verbesselt, Pol Coppin, Jan van Aardt, 2008 .

Hotspots of malignant pleural mesothelioma in Western Europe.

K. Nackaerts, T. Nawrot, Valerie Nuyts, 2018, Translational lung cancer research.

OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)

K. Nackaerts, T. Owonikoko, D. Spigel, 2017 .

Can flocs and water stable soil aggregates be differentiated within fluvial systems

K. Nackaerts, D. Walling, I. Droppo, 2005 .

Treatment of unresectable stage III NSCLC: Real world cohort study and literature review.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2023, Cancer treatment and research communications.

Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

K. Nackaerts, G. Bormans, E. Van Cutsem, 2023, EJNMMI Research.

Lung cancer screening white paper: a slippery step forward?

H. Kauczor, K. Nackaerts, M. Prokop, 2015, European Respiratory Journal.

Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy

K. Nackaerts, G. Pravettoni, S. Petrocchi, 2021, Frontiers in Pharmacology.

Risk stratification based on screening history: the NELSON lung cancer screening study

H. D. de Koning, K. Nackaerts, H. Groen, 2017, Thorax.

Comparative performance of a modified change vector analysis in forest change detection

Pol Coppin, Bart Muys, Kris Nackaerts, 2005 .

Mucormycosis, a threatening opportunistic mycotic infection.

K. Nackaerts, G. Deneffe, M. Boogaerts, 1999, Acta clinica Belgica.

What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences

K. Nackaerts, G. Pravettoni, I. Durosini, 2021, Frontiers in Pharmacology.

The PROBA-V mission: image processing and calibration

Stefan Adriaensen, Sindy Sterckx, Ils Reusen, 2014 .

Dépistage du cancer bronchique

K. Nackaerts, 2014 .

Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study

Rozemarijn Vliegenthart, Matthijs Oudkerk, Harry J M Groen, 2018, Thorax.

Sampling methodology for LAI measurements with LAI-2000 in small forest stands.

Pol Coppin, Martin Hermy, Bart Muys, 2000 .

Early detection and prevention of lung cancer

Stefan Diederich, Luc Thiberville, Benoit Nemery, 2002 .

In regards to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).

K. Nackaerts, Y. Lievens, P. Nafteux, 2007, International journal of radiation oncology, biology, physics.

WHAT HAVE QUANTITATIVE CHANGE INDICATORS AND FRACTAL DIMENSION IN COMMON

K. Nackaerts, B. Muys, P. Coppin, 2004 .

An uncommon histopathological diagnosis

K. Nackaerts, R. Sciot, C. Deroose, 2018, Breathe.

Mediastinal emphysema and small cell lung cancer (SCLC): a case-report.

K. Nackaerts, J. Vansteenkiste, E. Verbeken, 2005, Lung cancer.

Heparan sulfate proteoglycan expression in human lung‐cancer cells

K. Nackaerts, G. Deneffe, E. Verbeken, 1997, International journal of cancer.

Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial

H. C. Donker, H. Gietema, K. Nackaerts, 2023, European Journal of Epidemiology.

Quantification of growth patterns of screen-detected lung cancers: The NELSON study.

H. D. de Koning, K. Nackaerts, C. Weenink, 2017, Lung cancer.

Accuracy assessment of probabilistic visibilities

Gerard Govers, Jos Van Orshoven, Kris Nackaerts, 1999, Int. J. Geogr. Inf. Sci..

The use of Monte-Carlo techniques for the estimation of visibility

Kris Nackaerts, Gerard Govers, Lieven Loots, 1997 .

836 Detection of N2-disease in potentially operable non-small cell lung cancer with FDG-PET scan: A prospective study

K. Nackaerts, J. Bogaert, P. Dupont, 1997 .

Practical approach to patients presenting with multiple synchronous suspect lung lesions. A reflection on the current TNM classification based on 54 cases with complete follow-up

K. Nackaerts, J. Vansteenkiste, M. Demedts, 2001 .

Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging

C. Dooms, K. Nackaerts, S. Dymarkowski, 2014, European Radiology.

Implicit attitudes towards smoking predict long-term relapse in abstinent smokers

K. Nackaerts, J. de Houwer, Adriaan Spruyt, 2015, Psychopharmacology.

New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study.

H. D. de Koning, K. Nackaerts, H. Groen, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Management of lung nodules detected by volume CT scanning.

P. V. van Ooijen, H. Gietema, H. D. de Koning, 2009, The New England journal of medicine.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Lung cancer.

Single-celltranscriptomicsidentifies pathogenic T-helper 17.1 cells and pro-inflammatorymonocytesinimmune checkpoint inhibitor-related pneumonitis

C. Dooms, K. Nackaerts, D. Lambrechts, 2022 .

Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives

K. Nackaerts, F. Petrella, M. Casiraghi, 2023, Frontiers in Psychology.

Fuzzy Viewshed Analysis of the Hellenistic City Defence System at Sagalassos, Turkey

Marc Waelkens, Lieven Loots, K. Nackaerts, 1997 .

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial

H. D. de Koning, K. Nackaerts, H. Groen, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database.

C. Dooms, K. Nackaerts, B. Weynand, 2016, Lung cancer.

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

K. Nackaerts, J. Aerts, F. Grosso, 2017, The Lancet. Oncology.

Pemetrexed plus cisplatin (P+Cis) or pemetrexed plus carboplatin (P+Cb) for chemonaive patients (pts) with malignant pleural mesothelioma (MPM): Results of the International Expanded Access Program (EAP)

K. Nackaerts, R. Stahel, A. Santoro, 2007 .

Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)

K. Nackaerts, J. V. van Meerbeeck, O. Thas, 2016, Journal of breath research.

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

J. Crowley, G. Giaccone, A. Nicholson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation

K. Nackaerts, L. Annemans, P. Bartsch, 2009, Clinical drug investigation.

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

K. Nackaerts, F. de Marinis, K. Syrigos, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Dutch-Belgian lung cancer screening trial (NELSON): Recruitment and baseline screening results

H. Gietema, K. Nackaerts, M. Prokop, 2006 .

Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.

K. Nackaerts, P. Dendale, T. de Smedt, 2016, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Nicotine dependence and urinary nicotine, cotinine and hydroxycotinine levels in daily smokers

K. Nackaerts, P. Dendale, J. Loco, 2015 .

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

P. V. van Ooijen, H. D. de Koning, K. Nackaerts, 2018, Lung cancer.

Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.

K. Nackaerts, H. Groen, M. Oudkerk, 2017, Lung cancer.

397 Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC)

K. Nackaerts, B. Hellerstedt, S. Gadgeel, 2010 .

Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study.

K. Nackaerts, D. de Ruysscher, J. Vansteenkiste, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial.

K. Nackaerts, C. Weenink, J. Lammers, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

K. Nackaerts, E. Kellen, J. V. van Meerbeeck, 2010, American journal of respiratory and critical care medicine.